92 related articles for article (PubMed ID: 27164304)
1. Characteristics of Smoking Patients with Lung Cancer with Emphysematous Bullae.
Iwama E; Okamoto I; Yabuuchi H; Takayama K; Harada T; Matsuo Y; Tokunaga S; Baba E; Nakanishi Y
J Thorac Oncol; 2016 Sep; 11(9):1586-90. PubMed ID: 27164304
[TBL] [Abstract][Full Text] [Related]
2. Frequency of Epidermal Growth Factor Receptor Mutation in Smokers with Lung Cancer Without Pulmonary Emphysema.
Takeda K; Yamasaki A; Igishi T; Kawasaki Y; Ito-Nishii S; Izumi H; Sakamoto T; Touge H; Kodani M; Makino H; Yanai M; Tanaka N; Matsumoto S; Araki K; Nakamura H; Shimizu E
Anticancer Res; 2017 Feb; 37(2):765-771. PubMed ID: 28179328
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of underlying lung disease in smokers with epidermal growth factor receptor-mutant lung cancer.
Sekine A; Tamura K; Satoh H; Tanaka T; Tsunoda Y; Tanaka T; Takoi H; Lin SY; Yatagai Y; Hashizume T; Hayasihara K; Saito T
Oncol Rep; 2013 May; 29(5):2005-10. PubMed ID: 23467672
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status.
Hsu CH; Tseng CH; Chiang CJ; Hsu KH; Tseng JS; Chen KC; Wang CL; Chen CY; Yen SH; Chiu CH; Huang MS; Yu CJ; Tsai YH; Chen JS; Tsai CM; Chou TY; Lin KC; Tsai MH; Lee WC; Ku HY; Liu TW; Yang TY; Chang GC
Oncotarget; 2016 Jul; 7(29):46628-46635. PubMed ID: 27191886
[TBL] [Abstract][Full Text] [Related]
5. Mutation and polymorphism in the EGFR-TK domain associated with lung cancer.
Zhang W; Stabile LP; Keohavong P; Romkes M; Grandis JR; Traynor AM; Siegfried JM
J Thorac Oncol; 2006 Sep; 1(7):635-47. PubMed ID: 17409930
[TBL] [Abstract][Full Text] [Related]
6. Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose.
Li H; Pan Y; Li Y; Li C; Wang R; Hu H; Zhang Y; Ye T; Wang L; Shen L; Sun Y; Chen H
Lung Cancer; 2013 Jan; 79(1):8-13. PubMed ID: 23098378
[TBL] [Abstract][Full Text] [Related]
7. Impact of age on epidermal growth factor receptor mutation in lung cancer.
Ueno T; Toyooka S; Suda K; Soh J; Yatabe Y; Miyoshi S; Matsuo K; Mitsudomi T
Lung Cancer; 2012 Dec; 78(3):207-11. PubMed ID: 23036155
[TBL] [Abstract][Full Text] [Related]
8. Specificities of lung adenocarcinoma in women who have never smoked.
Mazières J; Rouquette I; Lepage B; Milia J; Brouchet L; Guibert N; Beau-Faller M; Validire P; Hofman P; Fouret P
J Thorac Oncol; 2013 Jul; 8(7):923-9. PubMed ID: 23608817
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathological characteristics, outcome and mutational profiles regarding non-small-cell lung cancer related to wood-smoke exposure.
Arrieta O; Campos-Parra AD; Zuloaga C; Avilés A; Sánchez-Reyes R; Manríquez ME; Covián-Molina E; Martínez-Barrera L; Meneses A; Cardona A; Borbolla-Escoboza JR
J Thorac Oncol; 2012 Aug; 7(8):1228-34. PubMed ID: 22659961
[TBL] [Abstract][Full Text] [Related]
10. No impact of passive smoke on the somatic profile of lung cancers in never-smokers.
Couraud S; Debieuvre D; Moreau L; Dumont P; Margery J; Quoix E; Duvert B; Cellerin L; Baize N; Taviot B; Coudurier M; Cadranel J; Missy P; Morin F; Mornex JF; Zalcman G; Souquet PJ;
Eur Respir J; 2015 May; 45(5):1415-25. PubMed ID: 25745045
[TBL] [Abstract][Full Text] [Related]
11. The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: a meta-analysis of prospective randomized trials.
Hasegawa Y; Ando M; Maemondo M; Yamamoto S; Isa S; Saka H; Kubo A; Kawaguchi T; Takada M; Rosell R; Kurata T; Ou SH
Oncologist; 2015 Mar; 20(3):307-15. PubMed ID: 25657199
[TBL] [Abstract][Full Text] [Related]
12. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
[TBL] [Abstract][Full Text] [Related]
13. Impact of Smoking History on the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer Harboring Activating Epidermal Growth Factor Receptor Mutations.
Igawa S; Sasaki J; Otani S; Ishihara M; Takakura A; Katagiri M; Masuda N
Oncology; 2015; 89(5):275-80. PubMed ID: 26335629
[TBL] [Abstract][Full Text] [Related]
14. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
Mounawar M; Mukeria A; Le Calvez F; Hung RJ; Renard H; Cortot A; Bollart C; Zaridze D; Brennan P; Boffetta P; Brambilla E; Hainaut P
Cancer Res; 2007 Jun; 67(12):5667-72. PubMed ID: 17575133
[TBL] [Abstract][Full Text] [Related]
15. CT screening for lung cancer: Importance of emphysema for never smokers and smokers.
Henschke CI; Yip R; Boffetta P; Markowitz S; Miller A; Hanaoka T; Wu N; Zulueta JJ; Yankelevitz DF;
Lung Cancer; 2015 Apr; 88(1):42-7. PubMed ID: 25698134
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic features of lung squamous cell cancer in never-smokers.
Huang Y; Wang R; Pan Y; Zhang Y; Li H; Cheng C; Zheng D; Zheng S; Li Y; Shen X; Hu H; Cai D; Wang S; Zhang Y; Xiang J; Sun Y; Zhang J; Chen H
Oncotarget; 2016 Jun; 7(24):35979-35988. PubMed ID: 27092882
[TBL] [Abstract][Full Text] [Related]
17. Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer.
Lee YJ; Cho BC; Jee SH; Moon JW; Kim SK; Chang J; Chung KY; Park IK; Choi SH; Kim JH
J Clin Oncol; 2010 Jan; 28(3):487-92. PubMed ID: 20008630
[TBL] [Abstract][Full Text] [Related]
18. EGFR mutations in non-small-cell lung cancer among smokers and non-smokers: a meta-analysis.
Ren JH; He WS; Yan GL; Jin M; Yang KY; Wu G
Environ Mol Mutagen; 2012 Jan; 53(1):78-82. PubMed ID: 22223435
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor mutations in lung adenocarcinoma in Malaysian patients.
Liam CK; Wahid MI; Rajadurai P; Cheah YK; Ng TS
J Thorac Oncol; 2013 Jun; 8(6):766-72. PubMed ID: 23575413
[TBL] [Abstract][Full Text] [Related]
20. EGFR mutation and lobar location of lung adenocarcinoma.
Tseng CH; Chen KC; Hsu KH; Tseng JS; Ho CC; Hsia TC; Su KY; Wu MF; Chiu KL; Liu CM; Wu TC; Chen HJ; Chen HY; Chang CS; Hsu CP; Hsia JY; Chuang CY; Lin CH; Chen JJW; Chen KY; Liao WY; Shih JY; Yu SL; Yu CJ; Yang PC; Yang TY; Chang GC
Carcinogenesis; 2016 Feb; 37(2):157-162. PubMed ID: 26645716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
